Gastroenterology Therapeutic Area Lead, US Medical Affairs – Immunology

Johnson & Johnson Innovative Medicine•Horsham, PA

32d•Hybrid

About The Position

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com About Immunology Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow. Our Immunology team leads in the development of transformational medicines for immunological disorders and illnesses. You can influence where medicine is going by restoring health to millions of people living with immune diseases. Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way. Learn more at https://www.jnj.com/innovative-medicine We are searching for the best talent for a Gastroenterology Therapeutic Area Lead, US Medical Affairs - Immunology based in Horsham, PA. Purpose: The Gastroenterology Therapeutic Area Lead, US Medical Affairs - Immunology is responsible for supervising a matrixed team advancing the scientific strategy and business plan for the Gastroenterology Therapeutic Area (TA). The role will also manage a team of direct reports. The strategic arms are to strive for Medical Affairs leadership in this therapeutic area by identifying and addressing key stakeholders’ needs through data generation, data dissemination, and special initiatives supporting our Gastroenterology products. Position reports to the Vice President, US Medical Affairs Gastroenterology & Autoantibody- Immunology.

Requirements

MD/DO degree required
A minimum of 10 years of combined Immunology and/or Gastroenterology/hepatology clinical and/or industry experience, with at least 5 years in industry is required
Gastroenterology or Immunology industry experience, including in clinical research/clinical trials is highly preferred; Medical Affairs experience highly preferred
Experience in Immunology or a related field is required; Gastroenterology experience is highly preferred
Previous direct people management experience is highly preferred
The successful candidate must have strong leadership skills with highly collaborative instincts
Experience in a multi-functional matrix organization is preferred
Ability to communicate clearly and effectively with basic and clinical scientists, as well as with regulatory and commercial colleagues is required
Excellent oral and written communication and presentation skills are required
Up to 25% travel (primarily domestic & limited international) is required
This position is located in Horsham, PA and follows a hybrid schedule of three days in the office and two days remotely per week

Responsibilities

Lead the Gastroenterology Medical Affairs team including the GI Integrated Evidence Team Leader, in developing a scientifically, strategically, and commercially sound strategy of evidence generation to support all approved and late development Gastroenterology assets.
Identify, prioritize, and oversee the implementation of innovative and compliant data dissemination approaches and data generation strategies, with cognizance of the continually changing healthcare environment and clinical practice patterns.
Drive the execution of the Gastroenterology Therapeutic Area strategy through collaboration with functional areas (including R&D and Commercial) and ensure the strategy is aligned and successfully executed across global medical affairs, GI MSL, publications, marketing, and market access teams
Lead both Gastroenterology Therapeutic Area employees and matrixed team partners in developing sophisticated and innovative scientific strategies, data generation activities and subsequent tactics. Create opportunities for key talent to assume future leadership roles.
Supervise the planning and execution of Phase 3b and 4 clinical trials, studies to address post marketing commitments, and the development of other evidence generation activities (such as those using RWE approaches), as well as the assessment, coordination and prioritization of collaborative and IIS studies.
Actively lead as a subject matter expert (SME) on internal and competitor data in relevant GI diseases and manage expertise on the GI MA team to provide advice and input to and support the Global Medical Affairs, R&D, Marketing, Sales, Market Access, New Business Development, Real World Value & Evidence, MSL, Medical Information, and Communications teams, shaping and influencing the collective strategy based on sound scientific principles, available data, and strategic insights.
Lead the Gastroenterology Therapeutic Area in annual business planning and be responsible for budget decisions within boundaries allocated by the Medical Affairs Leadership Team.
Serve as a core member of Medical Affairs Leadership Team, US Immunology Business Operations Leadership Team, and GI Integrated Strategy Team, and also serve as a co-lead of the GI Integrated Evidence Team.
Represent US Medical Affairs in various interactions with the global functions including clinical R&D, translational medicine, regulatory affairs/labelling, and global medical safety. This includes providing data, responses, and subject matter expertise for regulatory requests and documents, directly and through the team.
Serve as a key SME and driver of strategy and execution of publications from both the global and US perspectives
Provide strategic and scientific input on business development opportunities, pipeline assets (and related supportive clinical studies) to ensure necessary scientific rigor in study design and endpoints, as well as alignment with US strategic requirements.